CTL ontogeny and viral escape: implications for HIV-1 vaccine design
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 25 (3) , 138-142
- https://doi.org/10.1016/j.it.2004.01.004
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Impacts of Epitope Expression Kinetics and Class I Downregulation on the Antiviral Activity of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T LymphocytesJournal of Virology, 2004
- Determinants of HIV-1 Mutational Escape From Cytotoxic T LymphocytesThe Journal of Experimental Medicine, 2003
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- Study of Antigen-Processing Steps Reveals Preferences Explaining Differential Biological Outcomes of Two HLA-A2-Restricted Immunodominant Epitopes from Human Immunodeficiency Virus Type 1Journal of Virology, 2002
- Comparison of the efficacy of early versus late viral proteins in vaccination against SIVVaccine, 2002
- Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population LevelScience, 2002
- Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytesNature, 2002
- Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.Journal of Clinical Investigation, 1998
- ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROLAnnual Review of Immunology, 1997
- Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell linesArchiv für die gesamte Virusforschung, 1994